Throughout 2017, Malta has seen a slow but steady shift towards medical cannabis legalisation. Last month, a proposal put forth to the Maltese government that aims to facilitate the prescription of medical cannabis by general practitioners.
Saturday, 18th November marked a historic moment in the progression of medicinal cannabis treatment in Ireland. The Department of Health approved a three-month licence for tetrahydrocannabinol (THC) for the treatment of severe chronic pain.
With only a limited number of licences available for the recently announced Danish medical cannabis trial, the race is on to submit applications in advance of the deadline on the 31st of December. We explore the process and opportunity.
Europe is set to become the largest legal cannabis market in the world within the next five years.
Our report provides a detailed analysis of the medical, recreational and industrial sectors in 15 key European markets in addition to the various commercial, legal and social developments across the region.
There is currently a tide of cannabis reform sweeping throughout Europe, yet there is still a small number of states who have yet to make any effort on reform. This contrast in approach is reflected throughout Scandinavia - although there is still a long way to go before any of these countries become European forerunners.
Historically, Portugal is regarded as somewhat of a trailblazer when it comes to drug reform. Yet in the 15+ years that have followed, very little progress has been made and so Portugal seems set to remain rooted to its restrictive and inconsistent legal stance.
The New Opium Act was implemented in the Netherlands in 1976, which was to lead the way for the so called ‘Policy of Tolerance’. Initially, the policy was meant as a first step towards full regulation of soft drugs - although here we are 40 years later with very little progress.
Cannabis law reform has been a key talking point in British politics for many years. Yet, as the global attitude towards cannabis becomes more and more progressive, could the UK be left behind?
We have seen a tremendous global shift in attitudes towards cannabis so far this year, yet France continues to police its people with archaic (and increasingly isolated) laws.
The Czech Republic has had a complex relationship with cannabis. With the attitudes towards legal cannabis changing throughout Europe, could the country gain a foothold in the emerging marketplace?
A Bill calling for the legalisation of medical cannabis in Ireland was rejected by the Oireachtas Health Committee in July over fears that it could potentially “decriminalise the recreational use of the drug”
Coop, the Swiss supermarket chain, now stocks cannabis cigarettes high in CBD and initial sales have already been incredibly high.
Poland’s lower house of parliament (Sejm) has voted overwhelmingly in favour of making medical cannabis legal “under certain circumstances”.
On June 30th, the Greek Prime Minister, Alexis Tsipras and Health Minister, Andreas Xanthos announced that Greece is to become the seventh European country to legalise cannabis for medical use.
Following a petition which amassed over 60,000 signatures, the Catalonian Parliament decided to legalise the cultivation, consumption and distribution of cannabis throughout the autonomous Spanish region.
In April, in an effort to develop attitudes towards cannabis even further, The Radicali Italiani Movement announced plans to introduce a bill that proposes the full legalisation of adult cannabis use in Italy.
January 19th, 2017 saw a major development in Germany’s relationship with cannabis. German parliament unanimously voted to make it legal for doctors to prescribe cannabis-based treatments for ‘seriously ill’ patients.
The legal cannabis industry is the biggest potential new market in the world, with Europe’s recreational market alone currently being valued at €18bn. The European Cannabis Report™ from Prohibition Partners is the first major piece that uncovers the commercial opportunity of a legal cannabis market in Europe.